NetworkNewsBreaks Archive - Page 2103 of 2113

ThursdayOct 20, 2016 12:23 pm

Organovo Holdings, Inc. (ONVO) Prices $25M Public Offering

Organovo Holdings (NASDAQ: ONVO), a 3D bioprinting technology company, this morning announced the sale of 9 million shares of its common stock in an underwritten public offering at a price to the public of $2.75 per share for gross proceeds of approximately $25.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses and excluding any proceeds from the exercise of the underwriters’ option. The offering is expected to close on or about October 25, 2016. To view the press release, visit: http://nnw.fm/swQT2 About Organovo Holdings, Inc. Organovo designs and creates functional, three-dimensional human tissues for use in medical research and therapeutic…

ThursdayOct 20, 2016 12:22 pm

American Cannabis Company, Inc. (AMMJ) Shares Climb on Contract with Canadian Firm

American Cannabis Company, Inc.™ (OTCQB: AMMJ) is up more than 4% in morning trade after the full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, this morning announced its new design and consulting contract with a Canadian firm for the purpose of creating a cannabis Licensed Producer facility within the Atlantic provinces. The company said the multi-phase project will begin with the construction of an indoor facility. "The Canadian market is experiencing tremendous growth and we are excited to be working with a client who is positioned to excel within that market. They have a…

ThursdayOct 20, 2016 12:20 pm

Capricor Therapeutics, Inc. (CAPR) Trades Higher on News of $4.2M Grant from National Institutes of Health

Shares of Capricor Therapeutics (NASDAQ: CAPR) spiked 7% at the opening bell after the company announced that it has received a grant of up to $4.2 million from the National Institutes of Health to study CAP-2003 for hypoplastic left heart syndrome (HLHS). "We are excited to be part of this research effort to understand how CDC Exosomes, which are believed to be responsible for the regenerative effect of cardiosphere-derived cells, may be useful in the treatment of a serious congenital heart condition. We look forward to seeing if CAP-2003 can improve heart function, initially in pre-clinical models, and eventually in…

ThursdayOct 20, 2016 12:19 pm

xG Technology, Inc. (XGTI) Inks Binding Agreement to Acquire Vislink Communication Systems

xG Technology (NASDAQ: XGTI, XGTIW), a provider of critical wireless communications for use in challenging operating environments, this morning announced its binding agreement to acquire the assets of the Vislink Communication Systems division from Hungerford, United Kingdom-based Vislink, Plc. The deal is expected to close by year-end 2016. "We believe that Vislink chose to sell the division to a purchaser that would operate the business as a going concern, versus financial acquirers. We further believe that the combined business will create a market leader in video technology providing scale and global reach. Considering the inherent synergies with our business unit Integrated…

WednesdayOct 19, 2016 12:32 pm

Monaker Group, Inc.’s (MKGI) Maupintour Occupies Long-standing Position in Luxury Travel Market

The luxury travel market experienced a compound annual growth rate of 4.5% between 2011 and 2015, an upward trend expected to continue as more consumers pursue personalized experiences and top-notch services. The trend is likely to continue over the next decade, with new business opportunities and challenges for leading providers of luxury tours such as Monaker Group, Inc.’s (OTCQB: MKGI) Maupintour …a company with 65 years of experience in offering luxury and customizable private tours to the best destinations in the world. Some of the top luxury tours on the company’s roster this fall include a 9-day tour of traditional…

WednesdayOct 19, 2016 12:31 pm

Consumer Trends are Front and Center for Moxian, Inc. (MOXC)

Moxian (OTCQB: MOXC), a provider of social media marketing and promotion platforms, focuses on consumer behavior to help merchants better understand buyers’ decision making processes. “With consumer behavior data being at the forefront of e-commerce today, the goal is to know what consumers want before they even ask for it. Algorithms and big data are now enabling retailers to capitalize on their consumers by offering them what they want based on their shopping history and all the other variables … MOXC enables consumers and merchants to better interact thanks to consumer behavior data compiled in the Moxian database. With this…

WednesdayOct 19, 2016 12:30 pm

Ballard Power Systems (BLDP) Commissions Second Tranche of Fuel Cell Buses in China

Ballard Power Systems (NASDAQ: BLDP; TSX: BLD) this morning announced the commissioning and deployment of 10 fuel cell-powered buses in the City of Yunfu, in the Province of Guangdong, China, bringing the total number of buses deployed to 22 of the 300 planned to be deployed in the Cities of Foshan and Yunfu. The initiative is part of the Chinese Government's plan to address air quality in urban centers through zero tailpipe emission mass transit solutions. To view the full press release, visit: http://nnw.fm/ooZV1 About Ballard Power Systems Ballard Power Systems (NASDAQ: BLDP; TSX: BLD) provides clean energy products that…

WednesdayOct 19, 2016 12:29 pm

Marinus Pharmaceuticals, Inc. (MRNS) Shares Spike as Phase 1 Results for Ganaxolone Pave Way for Phase 2 Study

Marinus Pharmaceuticals (NASDAQ: MRNS) is trading more than 6% higher this morning after the company announced favorable results from its phase 1 dose-escalation study in which ganaxolone intravenous (IV) achieved dose levels targeted for efficacy in patients with status epilepticus (SE) – a life-threatening medical emergency associated with high mortality and limited treatments - and other indications. The phase 1 clinical study enrolled 36 subjects at Duke University Medical Center and was designed to determine the pharmacokinetics (PK), pharmacodynamics (PD), and safety of ganaxolone IV administered as an ascending bolus dose (Stage 1) or continuous infusion (Stage 2). Marinus is…

WednesdayOct 19, 2016 12:28 pm

Cerulean Pharma (CERU) Higher on $20M Purchase Agreement with Aspire Capital, Announces Novartis (NVS) Collaboration

Cerulean Pharma (NASDAQ: CERU) is trading higher following the effect of a $20 million common stock purchase agreement and a registration rights agreement with Aspire Capital Fund, LLC. Immediately following the execution of the purchase agreement, announced this morning, Aspire purchased 800,000 shares of common stock for $1.25 per share. The clinical-stage company developing nanoparticle-drug conjugates (NDCs) also this morning announced its strategic collaboration with Novartis (NYSE: NVS) to develop NDC product candidates combining Cerulean’s proprietary Dynamic Tumor Targeting™ technology with Novartis’ proprietary compounds directed at up to five targets. To view the full press releases, visit: http://nnw.fm/0Wzlg and http://nnw.fm/k20QU…

TuesdayOct 18, 2016 1:38 pm

Singlepoint, Inc. (SING) Maintains Sharp Focus on Opportunities within Vertical Markets

Singlepoint (OTC: SING) provides mobile technologies and payment solutions, participating in a competitive market dominated by bellwether brands. The company maintains its competitive edge by focusing on underserved verticals with significant potential. Its “Pay-by-Text combination of text messages and payments allows merchants to offer simpler mobile payment options to their customers … SinglePoint is currently in the process of leveraging this technology in two niche markets – daily fantasy sports and mobile auctions, markets where the holding company has purchased minority stock recently. The DFS vertical in particular is expected to bring significant value to the company, due to its…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks